| Year |
Citation |
Score |
| 2024 |
Jin R, Forbes CM, Miller NL, Lafin J, Strand DW, Case T, Cates JM, Liu Q, Ramirez-Solano M, Mohler JL, Matusik RJ. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance. The Prostate. PMID 38168866 DOI: 10.1002/pros.24661 |
0.453 |
|
| 2023 |
Celada SI, Li G, Celada LJ, Lu W, Kanagasabai T, Feng W, Cao Z, Salsabeel N, Mao N, Brown LK, Mark ZA, Izban MG, Ballard BR, Zhou X, Adunyah SE, ... Matusik RJ, et al. Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer. Molecular Oncology. PMID 37491794 DOI: 10.1002/1878-0261.13497 |
0.475 |
|
| 2022 |
Jin R, Forbes C, Miller NL, Strand D, Case T, Cates JM, Kim HH, Wages P, Porter NA, Mantione KM, Burke S, Mohler JL, Matusik RJ. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients. The Prostate. PMID 35821619 DOI: 10.1002/pros.24410 |
0.417 |
|
| 2022 |
Ochieng J, Korolkova OY, Li G, Jin R, Chen Z, Matusik RJ, Adunyah S, Sakwe AM, Ogunkua O. Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms. International Journal of Molecular Sciences. 23. PMID 35409390 DOI: 10.3390/ijms23074031 |
0.347 |
|
| 2021 |
Kanagasabai T, Li G, Shen TH, Gladoun N, Castillo-Martin M, Celada SI, Xie Y, Brown LK, Mark ZA, Ochieng J, Ballard BR, Cordon-Cardo C, Adunyah SE, Jin R, Matusik RJ, et al. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway. Cancer Letters. PMID 34610416 DOI: 10.1016/j.canlet.2021.09.041 |
0.354 |
|
| 2020 |
Kohrt SE, Awadallah WN, Phillips RA, Case TC, Jin R, Nanda JS, Yu X, Clark PE, Yi Y, Matusik RJ, Anderson PD, Grabowska MM. Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro. Molecular Cancer Therapeutics. PMID 33298586 DOI: 10.1158/1535-7163.MCT-20-0244 |
0.477 |
|
| 2020 |
Li G, Kanagasabai T, Lu W, Zou MR, Zhang SM, Celada SI, Izban MG, Liu Q, Lu T, Ballard BR, Zhou X, Adunyah SE, Matusik RJ, Yan Q, Chen Z. KDM5B is essential for the hyper-activation of PI3K/AKT signaling in prostate tumorigenesis. Cancer Research. PMID 32868382 DOI: 10.1158/0008-5472.Can-20-0505 |
0.618 |
|
| 2020 |
Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Vezina CM, Matusik RJ, Ricke WA, Grabowska MM. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia. The Prostate. PMID 32356572 DOI: 10.1002/Pros.23986 |
0.596 |
|
| 2020 |
Popovics* P, Awadallah WN, Kohrt S, Case TC, Miller NL, Ricke E, Huang W, Ramirez-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM. MP06-06 INCREASED EXPRESSION OF OSTEOPONTIN IN THE PROSTATE IS ASSOCIATED WITH THE CLINICAL PROGRESSION OF BPH The Journal of Urology. 203: e53. DOI: 10.1097/Ju.0000000000000820.06 |
0.454 |
|
| 2019 |
Connelly ZM, Yang S, Khater N, Orr AW, Jin R, Degraff D, Morrissey C, Corey E, Matusik R, Yu X. Abstract 59: The pioneer transcription factor FOXA2 regulates integrin alpha 1 expression controlling prostate cancer bone colonization Cancer Research. 79: 59-59. DOI: 10.1158/1538-7445.Sabcs18-59 |
0.545 |
|
| 2018 |
Connelly ZM, Yang S, Chen F, Yeh Y, Khater N, Jin R, Matusik R, Yu X. Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors. American Journal of Clinical and Experimental Urology. 6: 172-181. PMID 30510969 |
0.574 |
|
| 2018 |
Grabowska MM, Matusik RJ. Therapy-induced small-cell disease: from mouse to man and back. Nature Reviews. Urology. PMID 30177737 DOI: 10.1038/S41585-018-0084-Z |
0.482 |
|
| 2017 |
Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, ... ... Matusik R, et al. Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. European Urology. PMID 29258679 DOI: 10.1016/J.Eururo.2017.11.038 |
0.588 |
|
| 2017 |
Nandana S, Tripathi M, Duan P, Chu CY, Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, Zhau HE, Matusik RJ, Chung LW. Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis. Cancer Research. PMID 28108510 DOI: 10.1158/0008-5472.Can-16-0497 |
0.799 |
|
| 2017 |
Lu W, Lu S, Li B, Xie Y, Izban MG, Ballard BR, Sathyanarayana SA, Adunyah SE, Matusik RJ, Chen Z. Abstract 5326: EZH2 regulation through lysine 63 linked ubiquitination in prostate cancer Cancer Research. 77: 5326-5326. DOI: 10.1158/1538-7445.Am2017-5326 |
0.646 |
|
| 2017 |
Connelly ZM, Yang S, Li J, Matusik R, Yu X. Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer Endocrinology. 77: 1584-1584. DOI: 10.1158/1538-7445.Am2017-1584 |
0.517 |
|
| 2016 |
Lu W, Liu S, Li B, Xie Y, Izban MG, Ballard BR, Sathyanarayana SA, Adunyah SE, Matusik RJ, Chen Z. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer. Oncogene. PMID 27869166 DOI: 10.1038/Onc.2016.300 |
0.645 |
|
| 2016 |
Qiao J, Grabowska MM, Forestier-Roman IS, Mirosevich J, Case TC, Chung DH, Cates JM, Matusik RJ, Manning HC, Jin R. Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression. Oncotarget. PMID 27542219 DOI: 10.18632/Oncotarget.11326 |
0.563 |
|
| 2016 |
Austin DC, Strand DW, Love HL, Franco OE, Grabowska MM, Miller NL, Hameed O, Clark PE, Matusik RJ, Jin RJ, Hayward SW. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. The Prostate. PMID 27197599 DOI: 10.1002/Pros.23195 |
0.55 |
|
| 2016 |
Sanders DN, Grabowska M, Matusik R. Abstract B23: Neuroendocrine differentiation in prostate cancer and development Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B23 |
0.635 |
|
| 2016 |
Nandana S, Tripathi M, Duan P, Chu G, Zhau HE, Matusik RJ, Chung LWK. Abstract 4131: Blocking endogenous TBX2 abrogates prostate cancer bone metastasis through WNT signaling Cancer Research. 76: 4131-4131. DOI: 10.1158/1538-7445.Am2016-4131 |
0.815 |
|
| 2015 |
Austin DC, Strand DW, Love HL, Franco OE, Jang A, Grabowska MM, Miller NL, Hameed O, Clark PE, Fowke JH, Matusik RJ, Jin RJ, Hayward SW. NF-κB and androgen receptor variant expression correlate with human BPH progression. The Prostate. PMID 26709083 DOI: 10.1002/Pros.23140 |
0.576 |
|
| 2015 |
Grabowska MM, Kelly SM, Reese AL, Cates JM, Case TC, Zhang J, DeGraff DJ, Strand DW, Miller NL, Clark PE, Hayward SW, Gronostajski RM, Anderson PD, Matusik RJ. Nfib regulates transcriptional networks that control the development of prostatic hyperplasia. Endocrinology. en20151312. PMID 26677878 DOI: 10.1210/En.2015-1312 |
0.642 |
|
| 2015 |
Reddy OL, Cates JM, Gellert LL, Crist HS, Yang Z, Yamashita H, Taylor JA, Smith JA, Chang SS, Cookson MS, You C, Barocas DA, Grabowska MM, Ye F, Wu XR, ... ... Matusik RJ, et al. Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer. The American Journal of Pathology. 185: 1385-95. PMID 25907831 DOI: 10.1016/J.Ajpath.2015.01.014 |
0.421 |
|
| 2015 |
Lu W, Liu S, Li B, Xie Y, Adhiambo C, Yang Q, Ballard BR, Nakayama KI, Matusik RJ, Chen Z. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination. Oncotarget. 6: 771-88. PMID 25596733 DOI: 10.18632/Oncotarget.2718 |
0.626 |
|
| 2015 |
Lu W, Liu S, Li B, Xie Y, Adhiambo C, Yang Q, Ballard BR, Nakayama KI, Matusik RJ, Chen Z. Abstract 90: K63-linked JARID1B ubiquitination by TRAF6 contributes to aberrant elevation of JARID1B in prostate cancer Cancer Research. 75: 90-90. DOI: 10.1158/1538-7445.Am2015-90 |
0.64 |
|
| 2015 |
Parray A, Siddique HR, Langfald A, Singh P, Naito M, Matusik R, Schmitz I, Koochekpour S, Konety BR, Saleem M. Abstract 4678: A novel nuclear transporter for androgen receptor and AR-variant-7 in castration resistant prostate cancer: Ideal therapeutic target Cancer Research. 75: 4678-4678. DOI: 10.1158/1538-7445.Am2015-4678 |
0.57 |
|
| 2015 |
Saleem M, Konety B, Parray A, Siddique H, Matusik R, Naito M, Langfald A. MP66-14 IDENTIFYING NOVEL NUCLEAR TRANSPORTER OF AR AND AR(VARIANT) IN CRPC CELLS: POTENTIAL IMPLICATIONS IN THERAPY Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2367 |
0.319 |
|
| 2014 |
Jin R, Yamashita H, Yu X, Wang J, Franco OE, Wang Y, Hayward SW, Matusik RJ. Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression. Oncogene. PMID 25220414 DOI: 10.1038/Onc.2014.302 |
0.575 |
|
| 2014 |
Valkenburg KC, Yu X, De Marzo AM, Spiering TJ, Matusik RJ, Williams BO. Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. The Prostate. 74: 1506-20. PMID 25175604 DOI: 10.1002/Pros.22868 |
0.646 |
|
| 2014 |
Yu X, Cates JM, Morrissey C, You C, Grabowska MM, Zhang J, DeGraff DJ, Strand DW, Franco OE, Lin-Tsai O, Hayward SW, Matusik RJ. SOX2 expression in the developing, adult, as well as, diseased prostate. Prostate Cancer and Prostatic Diseases. 17: 301-9. PMID 25091041 DOI: 10.1038/Pcan.2014.29 |
0.636 |
|
| 2014 |
Xie Y, Liu S, Lu W, Yang Q, Williams KD, Binhazim AA, Carver BS, Matusik RJ, Chen Z. Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis. Molecular Oncology. 8: 1355-64. PMID 24910389 DOI: 10.1016/J.Molonc.2014.05.006 |
0.581 |
|
| 2014 |
DeGraff DJ, Grabowska MM, Case TC, Yu X, Herrick MK, Hayward WJ, Strand DW, Cates JM, Hayward SW, Gao N, Walter MA, Buttyan R, Yi Y, Kaestner KH, Matusik RJ. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 726-39. PMID 24840332 DOI: 10.1038/Labinvest.2014.64 |
0.74 |
|
| 2014 |
Grabowska MM, Elliott AD, DeGraff DJ, Anderson PD, Anumanthan G, Yamashita H, Sun Q, Friedman DB, Hachey DL, Yu X, Sheehan JH, Ahn JM, Raj GV, Piston DW, Gronostajski RM, ... Matusik RJ, et al. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression. Molecular Endocrinology (Baltimore, Md.). 28: 949-64. PMID 24801505 DOI: 10.1210/Me.2013-1213 |
0.527 |
|
| 2014 |
Jin R, Yi Y, Yull FE, Blackwell TS, Clark PE, Koyama T, Smith JA, Matusik RJ. NF-κB gene signature predicts prostate cancer progression. Cancer Research. 74: 2763-72. PMID 24686169 DOI: 10.1158/0008-5472.Can-13-2543 |
0.613 |
|
| 2014 |
Grabowska MM, DeGraff DJ, Yu X, Jin RJ, Chen Z, Borowsky AD, Matusik RJ. Mouse models of prostate cancer: picking the best model for the question. Cancer Metastasis Reviews. 33: 377-97. PMID 24452759 DOI: 10.1007/S10555-013-9487-8 |
0.56 |
|
| 2014 |
Li B, Lu W, Yang Q, Yu X, Matusik RJ, Chen Z. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer. The Prostate. 74: 421-32. PMID 24347472 DOI: 10.1002/Pros.22763 |
0.606 |
|
| 2014 |
Yu X, Matusik RJ, Jin R. RNASEL R462Q Mutation in Prostate Cancer Gene, Cell and Tissue. 2. DOI: 10.17795/GCT-24411 |
0.453 |
|
| 2013 |
Xiang Y, Qiu Q, Jiang M, Jin R, Lehmann BD, Strand DW, Jovanovic B, DeGraff DJ, Zheng Y, Yousif DA, Simmons CQ, Case TC, Yi J, Cates JM, Virostko J, ... ... Matusik RJ, et al. SPARCL1 suppresses metastasis in prostate cancer. Molecular Oncology. 7: 1019-30. PMID 23916135 DOI: 10.1016/J.Molonc.2013.07.008 |
0.52 |
|
| 2013 |
Majumdar S, Gong EM, Di Vizio D, Dreyfuss J, Degraff DJ, Hager MH, Park PJ, Bellmunt J, Matusik RJ, Rosenberg JE, Adam RM. Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior. Neoplasia (New York, N.Y.). 15: 749-60. PMID 23814487 DOI: 10.1593/Neo.121956 |
0.41 |
|
| 2013 |
Jin R, Sterling JA, Edwards JR, DeGraff DJ, Lee C, Park SI, Matusik RJ. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone. Plos One. 8: e60983. PMID 23577181 DOI: 10.1371/Journal.Pone.0060983 |
0.562 |
|
| 2013 |
Lu W, Xie Y, Ma Y, Matusik RJ, Chen Z. ARF represses androgen receptor transactivation in prostate cancer. Molecular Endocrinology (Baltimore, Md.). 27: 635-48. PMID 23449888 DOI: 10.1210/Me.2012-1294 |
0.621 |
|
| 2013 |
Strand DW, DeGraff DJ, Jiang M, Sameni M, Franco OE, Love HD, Hayward WJ, Lin-Tsai O, Wang AY, Cates JM, Sloane BF, Matusik RJ, Hayward SW. Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration. The American Journal of Pathology. 182: 449-59. PMID 23219716 DOI: 10.1016/J.Ajpath.2012.10.007 |
0.559 |
|
| 2013 |
Gupta A, Yu X, Case T, Paul M, Shen MM, Kaestner KH, Matusik RJ. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2. The Prostate. 73: 582-9. PMID 23060003 DOI: 10.1002/Pros.22598 |
0.633 |
|
| 2013 |
DeGraff DJ, Cates JM, Mauney JR, Clark PE, Matusik RJ, Adam RM. When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression. Urologic Oncology. 31: 802-11. PMID 21924649 DOI: 10.1016/J.Urolonc.2011.07.017 |
0.382 |
|
| 2013 |
Nandana S, Tripathi M, Gururajan M, Chu G, Matusik RJ, Chung LWK. Abstract C23: Blocking endogenous TBX2 expression abrogates prostate cancer bone metastasis in a xenograft mouse model Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C23 |
0.828 |
|
| 2013 |
Majumdar S, Gong E, Vizio DD, Dreyfuss J, DeGraff D, Hager M, Park P, Bellmunt J, Matusik R, Rosenberg J, Adam R. Abstract 4066: Loss of Sh3gl2/endophilin A1 is an early event in urothelial carcinoma that regulates malignant behavior. Cancer Research. 73: 4066-4066. DOI: 10.1158/1538-7445.Am2013-4066 |
0.431 |
|
| 2012 |
DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, ... Matusik RJ, et al. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. Plos One. 7: e36669. PMID 22590586 DOI: 10.1371/Journal.Pone.0036669 |
0.462 |
|
| 2012 |
DeGraff DJ, Matusik RJ. Gender specific differences in bladder cancer. The Journal of Urology. 188: 10-1. PMID 22583637 DOI: 10.1016/J.Juro.2012.04.037 |
0.358 |
|
| 2012 |
Sarveswaran S, Jin RJ, Matusik RJ, Ghosh J. Abstract 2255: Inhibition of 5-lipoxygenase interrupts c-Myc oncogenic signaling Cancer Research. 72: 2255-2255. DOI: 10.1158/1538-7445.Am2012-2255 |
0.641 |
|
| 2012 |
Gong Y, Lu W, Xie Y, Yang Q, Matusik RJ, Chen Z. Abstract B23: Curcumin suppresses the growth and metastasis of prostate cancer cells by downregulation of SKP2. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B23 |
0.628 |
|
| 2010 |
Yu X, Wang Y, DeGraff DJ, Wills ML, Matusik RJ. Wnt/β-catenin activation promotes prostate tumor progression in a mouse model. Oncogene. 30: 1868-79. PMID 21151173 DOI: 10.1038/Onc.2010.560 |
0.536 |
|
| 2010 |
Lu JP, Zhang J, Kim K, Case TC, Matusik RJ, Chen YH, Wolfe M, Nopparat J, Lu Q. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer. Molecular Cancer. 9: 304. PMID 21106062 DOI: 10.1186/1476-4598-9-304 |
0.635 |
|
| 2010 |
Zhang J, Gao N, DeGraff DJ, Yu X, Sun Q, Case TC, Kasper S, Matusik RJ. Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression. The Prostate. 70: 934-51. PMID 20209642 DOI: 10.1002/Pros.21128 |
0.691 |
|
| 2010 |
Nandana S, Ellwood-Yen K, Sawyers C, Wills M, Weidow B, Case T, Vasioukhin V, Matusik R. Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model. The Prostate. 70: 591-600. PMID 19938013 DOI: 10.1002/Pros.21093 |
0.833 |
|
| 2010 |
Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B, Yi Y, Magnuson MA, Roy-Burman P, Matusik RJ, Shappell SB, Hayward SW. Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy Cell Death and Differentiation. 17: 469-481. PMID 19834493 DOI: 10.1038/Cdd.2009.148 |
0.51 |
|
| 2010 |
Boachie AM, Degraff D, Yu X, Sun Q, Friedman D, Gronostajski R, Matusik R. Abstract 1231: Nuclear Factor I family members interact with FoxA1 to regulate androgen responsive promoters Cancer Research. 70: 1231-1231. DOI: 10.1158/1538-7445.Am10-1231 |
0.544 |
|
| 2009 |
Sun Q, Yu X, Degraff DJ, Matusik RJ. Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression. Molecular Endocrinology (Baltimore, Md.). 23: 2038-47. PMID 19846536 DOI: 10.1210/Me.2009-0092 |
0.583 |
|
| 2009 |
Yi Y, Nandana S, Case T, Nelson C, Radmilovic T, Matusik RJ, Tsuchiya KD. Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer. Molecular Cytogenetics. 2: 18. PMID 19781100 DOI: 10.1186/1755-8166-2-18 |
0.792 |
|
| 2009 |
Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Ishii K, Hayward SW, Matusik RJ, Bhowmick NA. Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation; Research in Biological Diversity. 77: 95-102. PMID 19281768 DOI: 10.1016/J.Diff.2008.09.012 |
0.585 |
|
| 2009 |
Yu X, Wang Y, Jiang M, Bierie B, Roy-Burman P, Shen MM, Taketo MM, Wills M, Matusik RJ. Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration. The Prostate. 69: 249-62. PMID 18991257 DOI: 10.1002/Pros.20877 |
0.524 |
|
| 2008 |
Thomas JC, Oottamasathien S, Makari JH, Honea L, Sharif-Afshar AR, Wang Y, Adams C, Wills ML, Bhowmick NA, Adams MC, Brock JW, Hayward SW, Matusik RJ, Pope JC. Temporal-spatial protein expression in bladder tissue derived from embryonic stem cells. The Journal of Urology. 180: 1784-9. PMID 18721943 DOI: 10.1016/J.Juro.2008.03.098 |
0.337 |
|
| 2008 |
Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Cancer Research. 68: 6762-9. PMID 18701501 DOI: 10.1158/0008-5472.Can-08-0107 |
0.618 |
|
| 2008 |
Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Research. 68: 4709-18. PMID 18559517 DOI: 10.1158/0008-5472.Can-07-6289 |
0.626 |
|
| 2008 |
Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ. Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Research. 68: 3601-8. PMID 18483241 DOI: 10.1158/0008-5472.Can-08-0073 |
0.664 |
|
| 2008 |
Matusik RJ, Jin RJ, Sun Q, Wang Y, Yu X, Gupta A, Nandana S, Case TC, Paul M, Mirosevich J, Oottamasathien S, Thomas J. Prostate epithelial cell fate. Differentiation; Research in Biological Diversity. 76: 682-98. PMID 18462434 DOI: 10.1111/J.1432-0436.2008.00276.X |
0.816 |
|
| 2008 |
Levitin F, Weiss M, Hahn Y, Stern O, Papke RL, Matusik R, Nandana SR, Ziv R, Pichinuk E, Salame S, Bera T, Vincent J, Lee B, Pastan I, Wreschner DH. PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity. The Journal of Biological Chemistry. 283: 16928-39. PMID 18387948 DOI: 10.1074/Jbc.M801454200 |
0.792 |
|
| 2008 |
Gupta A, Wang Y, Browne C, Kim S, Case T, Paul M, Wills ML, Matusik RJ. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells. The Prostate. 68: 50-60. PMID 18004726 DOI: 10.1002/Pros.20650 |
0.662 |
|
| 2008 |
Jin R, Lho Y, Connelly L, Blackwell TS, Yull FE, Matusik RJ. THE NF-κB PATHWAY CONTROLS PROGRESSION OF PROSTATE CANCER TO ANDROGEN INDEPENDENT GROWTH Journal of Urology. 179: 393-393. DOI: 10.1016/S0022-5347(08)61151-9 |
0.56 |
|
| 2007 |
Suzuki K, Yu X, Chaurand P, Araki Y, Lareyre JJ, Caprioli RM, Orgebin-Crist MC, Matusik RJ. Epididymis-specific lipocalin promoters. Asian Journal of Andrology. 9: 515-21. PMID 17589789 DOI: 10.1111/J.1745-7262.2007.00300.X |
0.394 |
|
| 2007 |
Oottamasathien S, Wang Y, Williams K, Franco OE, Wills ML, Thomas JC, Saba K, Sharif-Afshar AR, Makari JH, Bhowmick NA, DeMarco RT, Hipkens S, Magnuson M, Brock JW, Hayward SW, ... ... Matusik RJ, et al. Directed differentiation of embryonic stem cells into bladder tissue. Developmental Biology. 304: 556-66. PMID 17289017 DOI: 10.1016/J.Ydbio.2007.01.010 |
0.338 |
|
| 2007 |
Mirosevich J, Gao N, Gupta A, Twardowski PW, Wilson TG, Shappell SB, Jove R, Matusik RJ. 1129: The Expression and Role of Foxatranscription Factor Proteins in Prostate Cancer Progression Journal of Urology. 177: 372-373. DOI: 10.1016/S0022-5347(18)31343-0 |
0.71 |
|
| 2006 |
Wang Y, Kasper S, Yuan J, Jin RJ, Zhang J, Ishii K, Wills ML, Hayward SW, Matusik RJ. Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 1074-88. PMID 16894353 DOI: 10.1038/Labinvest.3700463 |
0.631 |
|
| 2006 |
Yu X, Suzuki K, Wang Y, Gupta A, Jin R, Orgebin-Crist MC, Matusik R. The role of forkhead box A2 to restrict androgen-regulated gene expression of lipocalin 5 in the mouse epididymis. Molecular Endocrinology (Baltimore, Md.). 20: 2418-31. PMID 16740652 DOI: 10.1210/Me.2006-0008 |
0.412 |
|
| 2006 |
Lees JR, Charbonneau B, Swanson AK, Jensen R, Zhang J, Matusik R, Ratliff TL. Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology. 117: 248-61. PMID 16423061 DOI: 10.1111/J.1365-2567.2005.02293.X |
0.478 |
|
| 2006 |
Suzuki K, Yu X, Chaurand P, Araki Y, Lareyre JJ, Caprioli RM, Matusik RJ, Orgebin-Crist MC. Epididymis-specific promoter-driven gene targeting: A transcription factor which regulates epididymis-specific gene expression Molecular and Cellular Endocrinology. 250: 184-189. PMID 16414179 DOI: 10.1016/J.Mce.2005.12.043 |
0.395 |
|
| 2006 |
Lees JR, Charbonneau B, Hayball JD, Diener K, Brown M, Matusik R, Cohen MB, Ratliff TL. T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. The Prostate. 66: 578-90. PMID 16388504 DOI: 10.1002/Pros.20307 |
0.581 |
|
| 2006 |
Uchida K, Masumori N, Takahashi A, Itoh N, Kato K, Matusik RJ, Tsukamoto T. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP. The Prostate. 66: 536-45. PMID 16372327 DOI: 10.1002/Pros.20369 |
0.625 |
|
| 2006 |
Shao TC, Li HL, Kasper S, Matusik R, Ittmann M, Cunningham GR. Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. The Prostate. 66: 369-76. PMID 16302273 DOI: 10.1002/Pros.20354 |
0.561 |
|
| 2006 |
Mirosevich J, Gao N, Gupta A, Shappell SB, Jove R, Matusik RJ. Expression and role of Foxa proteins in prostate cancer. The Prostate. 66: 1013-28. PMID 16001449 DOI: 10.1002/Pros.20299 |
0.757 |
|
| 2005 |
Yu X, Gupta A, Wang Y, Suzuki K, Mirosevich J, Orgebin-Crist MC, Matusik RJ. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Annals of the New York Academy of Sciences. 1061: 77-93. PMID 16467259 DOI: 10.1196/Annals.1336.009 |
0.574 |
|
| 2005 |
Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, et al. Molecular alterations in primary prostate cancer after androgen ablation therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6823-34. PMID 16203770 DOI: 10.1158/1078-0432.Ccr-05-0585 |
0.59 |
|
| 2005 |
Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development (Cambridge, England). 132: 3431-43. PMID 15987773 DOI: 10.1242/Dev.01917 |
0.727 |
|
| 2005 |
Ishii K, Shappell SB, Matusik RJ, Hayward SW. Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 1086-103. PMID 15980886 DOI: 10.1038/Labinvest.3700310 |
0.462 |
|
| 2005 |
Yi Y, Mirosevich J, Shyr Y, Matusik R, George AL. Coupled analysis of gene expression and chromosomal location Genomics. 85: 401-412. PMID 15718107 DOI: 10.1016/J.Ygeno.2004.11.011 |
0.404 |
|
| 2005 |
Mirosevich J, Gao N, Matusik RJ. Expression of Foxa transcription factors in the developing and adult murine prostate. The Prostate. 62: 339-52. PMID 15389796 DOI: 10.1002/Pros.20131 |
0.671 |
|
| 2005 |
Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL. Myc-driven murine prostate cancer shares molecular features with human prostate tumors Cancer Cell. 8: 485. DOI: 10.1016/J.Ccr.2005.11.010 |
0.611 |
|
| 2004 |
Suzuki K, Lareyre JJ, Sánchez D, Gutierrez G, Araki Y, Matusik RJ, Orgebin-Crist MC. Molecular evolution of epididymal lipocalin genes localized on mouse chromosome 2. Gene. 339: 49-59. PMID 15363845 DOI: 10.1016/J.Gene.2004.06.027 |
0.328 |
|
| 2004 |
Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell. 6: 185-95. PMID 15324701 DOI: 10.1016/J.Ccr.2004.07.008 |
0.62 |
|
| 2004 |
Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Cancer Research. 64: 5489-95. PMID 15289359 DOI: 10.1158/0008-5472.Can-03-3117 |
0.598 |
|
| 2004 |
Kirchhoff C, Araki Y, Huhtaniemi I, Matusik RJ, Osterhoff C, Poutanen M, Samalecos A, Sipilä P, Suzuki K, Orgebin-Crist MC. Immortalization by large T-antigen of the adult epididymal duct epithelium Molecular and Cellular Endocrinology. 216: 83-94. PMID 15109748 DOI: 10.1016/J.Mce.2003.10.073 |
0.355 |
|
| 2004 |
Masumori N, Tsuchiya K, Tu WH, Lee C, Kasper S, Tsukamoto T, Shappell SB, Matusik RJ. An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line. The Journal of Urology. 171: 439-42. PMID 14665950 DOI: 10.1097/01.Ju.0000099826.63103.94 |
0.825 |
|
| 2004 |
Zhang J, Gao N, Kasper S, Reid K, Nelson C, Matusik RJ. An androgen-dependent upstream enhancer is essential for high levels of probasin gene expression. Endocrinology. 145: 134-48. PMID 14500578 DOI: 10.1210/En.2003-0568 |
0.639 |
|
| 2003 |
Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell. 4: 223-38. PMID 14522256 DOI: 10.1016/S1535-6108(03)00197-1 |
0.637 |
|
| 2003 |
Wen Y, Giri D, Yan DH, Spohn B, Zinner RG, Xia W, Thompson TC, Matusik RJ, Hung MC. Prostate-specific antitumor activity by probasin promoter-directed p202 expression. Molecular Carcinogenesis. 37: 130-7. PMID 12884364 DOI: 10.1002/Mc.10129 |
0.611 |
|
| 2003 |
Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, Moses HL, Matusik RJ. The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia (New York, N.Y.). 5: 267-77. PMID 12869309 DOI: 10.1016/S1476-5586(03)80058-1 |
0.808 |
|
| 2003 |
Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Molecular Endocrinology (Baltimore, Md.). 17: 1484-507. PMID 12750453 DOI: 10.1210/Me.2003-0020 |
0.677 |
|
| 2003 |
Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Research. 63: 2256-67. PMID 12727848 |
0.55 |
|
| 2003 |
Fouchécourt S, Lareyre JJ, Chaurand P, Dague BB, Suzuki K, Ong DE, Olson GE, Matusik RJ, Caprioli RM, Orgebin-Crist MC. Identification, immunolocalization, regulation, and postnatal development of the lipocalin EP17 (Epididymal Protein of 17 Kilodaltons) in the mouse and rat epididymis Endocrinology. 144: 887-900. PMID 12586765 DOI: 10.1210/En.2002-220932 |
0.337 |
|
| 2003 |
Suzuki K, Araki Y, Zhu MY, Lareyre JJ, Matusik RJ, Orgebin-Crist MC. The 5'-flanking region of the murine epididymal protein of 17 kilodaltons gene targets transgene expression in the epididymis. Endocrinology. 144: 877-86. PMID 12586764 DOI: 10.1210/En.2002-220757 |
0.374 |
|
| 2002 |
Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N. Tissue-specific transcriptional targeting of a replication-competent retroviral vector. Journal of Virology. 76: 12783-91. PMID 12438603 DOI: 10.1128/Jvi.76.24.12783-12791.2002 |
0.472 |
|
| 2002 |
Araki Y, Suzuki K, Matusik RJ, Obinata M, Orgebin-Crist MC. Immortalized epididymal cell lines from transgenic mice overexpressing temperature-sensitive simian virus 40 large T-antigen gene. Journal of Andrology. 23: 854-69. PMID 12399533 DOI: 10.1002/J.1939-4640.2002.Tb02344.X |
0.418 |
|
| 2002 |
Song Z, Wu X, Powell WC, Cardiff RD, Cohen MB, Tin RT, Matusik RJ, Miller GJ, Roy-Burman P. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Research. 62: 5096-105. PMID 12208767 |
0.543 |
|
| 2001 |
Andriani F, Nan B, Yu J, Li X, Weigel NL, McPhaul MJ, Kasper S, Kagawa S, Fang B, Matusik RJ, Denner L, Marcelli M. Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells. Journal of the National Cancer Institute. 93: 1314-24. PMID 11535706 DOI: 10.1093/Jnci/93.17.1314 |
0.571 |
|
| 2001 |
Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ, Sangiorgi FO, Maxson RE, Sucov HM, Roy-Burman P. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mechanisms of Development. 101: 61-9. PMID 11231059 DOI: 10.1016/S0925-4773(00)00551-7 |
0.616 |
|
| 2001 |
Lareyre JJ, Winfrey VP, Kasper S, Ong DE, Matusik RJ, Olson GE, Orgebin-Crist MC. Gene duplication gives rise to a new 17-kilodalton lipocalin that shows epididymal region-specific expression and testicular factor(s) regulation. Endocrinology. 142: 1296-308. PMID 11181548 DOI: 10.1210/Endo.142.3.8045 |
0.37 |
|
| 2001 |
Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Molecular Endocrinology (Baltimore, Md.). 15: 46-56. PMID 11145738 DOI: 10.1210/Mend.15.1.0581 |
0.471 |
|
| 2001 |
Lareyre JJ, Reid K, Nelson C, Kasper S, Rennie PS, Orgebin-Crist MC, Matusik RJ. Characterization of an androgen-specific response region within the 5' flanking region of the murine epididymal retinoic acid binding protein gene. Biology of Reproduction. 63: 1881-92. PMID 11090461 DOI: 10.1095/Biolreprod63.6.1881 |
0.441 |
|
| 2000 |
Zhang J, Thomas TZ, Kasper S, Matusik RJ. A Small Composite Probasin Promoter Confers High Levels of Prostate-Specific Gene Expression through Regulation by Androgens and Glucocorticoids in Vitro and in Vivo* *This work was supported by R01-DK-55748 from the NIH and the Frances Williams Preston Laboratories of the T. J. Martell Foundation. Transgenic mice were bred by the Transgenic Core/ES Cell Shared Resource of the Vanderbilt-Ingram Cancer Center (NCI Grant 2P30-CA-68485-05). Endocrinology. 141: 4698-4710. PMID 28204369 DOI: 10.1210/Endo.141.12.7837 |
0.645 |
|
| 2000 |
Kasper S, Matusik RJ. Rat probasin: structure and function of an outlier lipocalin. Biochimica Et Biophysica Acta. 1482: 249-58. PMID 11058766 DOI: 10.1016/S0167-4838(00)00170-9 |
0.492 |
|
| 1999 |
Kasper S, Rennie PS, Bruchovsky N, Lin L, Cheng H, Snoek R, Dahlman-Wright K, Gustafsson JA, Shiu RP, Sheppard PC, Matusik RJ. Selective activation of the probasin androgen-responsive region by steroid hormones. Journal of Molecular Endocrinology. 22: 313-25. PMID 10343290 DOI: 10.1677/Jme.0.0220313 |
0.411 |
|
| 1999 |
Lareyre JJ, Thomas TZ, Zheng WL, Kasper S, Ong DE, Orgebin-Crist MC, Matusik RJ. A 5-kilobase pair promoter fragment of the murine epididymal retinoic acid-binding protein gene drives the tissue-specific, cell-specific, and androgen-regulated expression of a foreign gene in the epididymis of transgenic mice. The Journal of Biological Chemistry. 274: 8282-90. PMID 10075734 DOI: 10.1074/Jbc.274.12.8282 |
0.42 |
|
| 1998 |
Snoek R, Bruchovsky N, Kasper S, Matusik RJ, Gleave M, Sato N, Mawji NR, Rennie PS. Differential transactivation by the androgen receptor in prostate cancer cells. The Prostate. 36: 256-63. PMID 9719026 DOI: 10.1002/(Sici)1097-0045(19980901)36:4<256::Aid-Pros7>3.0.Co;2-D |
0.608 |
|
| 1998 |
Lareyre JJ, Mattéi MG, Kasper S, Ong DE, Matusik RJ, Orgebin-Crist MC. Genomic organization and chromosomal localization of the murine epididymal retinoic acid-binding protein (mE-RABP) gene. Molecular Reproduction and Development. 50: 387-95. PMID 9669522 DOI: 10.1002/(Sici)1098-2795(199808)50:4<387::Aid-Mrd2>3.0.Co;2-E |
0.307 |
|
| 1998 |
Green JE, Greenberg NM, Ashendel CL, Barrett JC, Boone C, Getzenberg RH, Henkin J, Matusik R, Janus TJ, Scher HI. Workgroup 3: transgenic and reconstitution models of prostate cancer. The Prostate. 36: 59-63. PMID 9650918 DOI: 10.1002/(Sici)1097-0045(19980615)36:1<59::Aid-Pros11>3.0.Co;2-H |
0.61 |
|
| 1998 |
Lareyre JJ, Zheng WL, Zhao GQ, Kasper S, Newcomer ME, Matusik RJ, Ong DE, Orgebin-Crist MC. Molecular cloning and hormonal regulation of a murine epididymal retinoic acid-binding protein messenger ribonucleic acid. Endocrinology. 139: 2971-81. PMID 9607808 DOI: 10.1210/Endo.139.6.6074 |
0.344 |
|
| 1998 |
Bai GE, Kasper S, Matusik RJ, Rennie PS, Moshier JA, Krongrad A. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells Journal of Andrology. 19: 127-135. PMID 9570735 DOI: 10.1002/J.1939-4640.1998.Tb01981.X |
0.596 |
|
| 1998 |
Chan J, Song CS, Matusik RJ, Chatterjee B, Roy AK. Inhibition of androgen action by dehydroepiandrosterone sulfotransferase transfected in PC-3 prostate cancer cells. Chemico-Biological Interactions. 109: 267-78. PMID 9566751 DOI: 10.1016/S0009-2797(97)00138-5 |
0.578 |
|
| 1997 |
Yan Y, Sheppard PC, Kasper S, Lin L, Hoare S, Kapoor A, Dodd JG, Duckworth ML, Matusik RJ. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. The Prostate. 32: 129-39. PMID 9215401 DOI: 10.1002/(Sici)1097-0045(19970701)32:2<129::Aid-Pros8>3.0.Co;2-H |
0.581 |
|
| 1997 |
Snoek R, Rennie PS, Kasper S, Matusik RJ, Bruchovsky N. Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides. The Journal of Steroid Biochemistry and Molecular Biology. 59: 243-50. PMID 9010316 DOI: 10.1016/S0960-0760(96)00116-1 |
0.476 |
|
| 1996 |
Leonard M, Sareen S, Hills K, Sheppard P, Matusik R. Early Characterization of a Novel Metastatic Disease Model of Murine Neuroblastoma Journal of Urology. 156: 696-700. DOI: 10.1016/S0022-5347(01)65788-4 |
0.317 |
|
| 1995 |
Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proceedings of the National Academy of Sciences of the United States of America. 92: 3439-43. PMID 7724580 DOI: 10.1073/Pnas.92.8.3439 |
0.666 |
|
| 1995 |
Dubé JY, Chapdelaine P, Guerin S, Leclerc S, Rennie PS, Matusik RJ, Tremblay RR. Search for androgen response elements in the proximal promoter of the canine prostate arginine esterase gene. Journal of Andrology. 16: 304-311. DOI: 10.1002/J.1939-4640.1995.Tb00534.X |
0.52 |
|
| 1989 |
Spence AM, Sheppard PC, Davie JR, Matuo Y, Nishi N, McKeehan WL, Dodd JG, Matusik RJ. Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin. Proceedings of the National Academy of Sciences of the United States of America. 86: 7843-7. PMID 2682630 DOI: 10.1073/Pnas.86.20.7843 |
0.411 |
|
| 1989 |
Matuq Y, Adams PS, Nishi N, Yasumitsu H, Crabb JW, Matusik RJ, McKeehan WL. The androgen-dependent rat prostate protein, probasin, is a heparin-binding protein that co-purifies with heparin-binding growth factor-1. In Vitro Cellular & Developmental Biology – Plant. 25: 581-584. PMID 2472375 DOI: 10.1007/Bf02623572 |
0.393 |
|
| 1989 |
Sweetland R, Sheppard PC, Dodd JG, Matusik RJ. Post-castration rebound of an androgen regulated prostatic gene. Molecular and Cellular Biochemistry. 84: 3-15. PMID 2466196 DOI: 10.1007/Bf00235188 |
0.511 |
|
| 1986 |
Dodd JG, Kreis C, Sheppard PC, Hamel A, Matusik RJ. Effect of androgens on mRNA for a secretory protein of rat dorsolateral prostate and seminal vesicles. Molecular and Cellular Endocrinology. 47: 191-200. PMID 3758473 DOI: 10.1016/0303-7207(86)90112-7 |
0.534 |
|
| 1986 |
Matusik RJ, Kreis C, McNicol P, Sweetland R, Mullin C, Fleming WH, Dodd JG. Regulation of prostatic genes: role of androgens and zinc in gene expression. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 64: 601-7. PMID 3741677 DOI: 10.1139/O86-083 |
0.478 |
|
| 1985 |
Fleming WH, Murphy PR, Murphy LJ, Hatton TW, Matusik RJ, Friesen HG. Human growth hormone induces and maintains C-myc gene expression in Nb2 lymphoma cells Endocrinology. 117: 2547-2549. PMID 4065045 DOI: 10.1210/Endo-117-6-2547 |
0.354 |
|
| 1980 |
Rosen JM, Matusik RJ, Richards DA, Gupta P, Rodgers JR. Multihormonal regulation of casein gene expression at the transcriptional and posttransciptional levels in the mammary gland. Recent Progress in Hormone Research. 36: 157-93. PMID 6997941 DOI: 10.1016/B978-0-12-571136-4.50011-5 |
0.339 |
|
| 1979 |
Guyette WA, Matusik RJ, Rosen JM. Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell. 17: 1013-23. PMID 487427 DOI: 10.1016/0092-8674(79)90340-4 |
0.321 |
|
| Show low-probability matches. |